U.S. pharmaceutical industry

U.S. total medicine spending 2002-2018

Leading therapy areas for U.S. drug spending 2018

U.S. top 20 prescribed drugs based on sales 2018

Top U.S. pharma products by prescriptions 2018

Pharmaceutical channel distribution by U.S. spending 2014-2018

U.S. biopharmaceutical export volume 2002-2017

2019 list of top U.S. biotech and pharmaceutical companies based on revenue

Pharmaceutical corporations by U.S. revenue 2018

Pfizer's total revenue 2006-2018

Johnson & Johnson's total revenue 2005-2018

AbbVie's revenue 2010-2018

Research and development expenditure: U.S. pharmaceutical industry 1995-2018

U.S. pharma industry R&D spending as a percent of total revenues 1990-2018

Pharmaceuticals: biopharma medicines in development in 2019, by category

Pharmaceuticals: cost of drug development in the U.S. since 1975

Number of novel drugs approved annually by CDER 2008-2018

Number of orphan designations accepted in the U.S. 2003-2018

U.S. sales growth of new brand medicines 2014-2018

R&D expenditure per employee in U.S. sectors 2001-2015

Unbranded generics revenue top corporations in U.S. 2016-2017

Spending change on branded and generic medicines in the U.S. 2013-2018

U.S. brand and generic prescription drug revenue 2005-2018

Branded vs. generic U.S. drug prescriptions dispensed 2005-2018

Savings through generic drug usage in the U.S. 2008-2018

Projected decrease in brand drug spending due to patent loss in the U.S. 2013-2023

World pharmaceutical sales by region forecast 2022

Top branded biologic drugs in the U.S. that will go generic by 2028

Leading U.S. pharmaceutical products by revenue 2024

Projected 2024 revenue for top drugs approved U.S. 2018

U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection

U.S. adults impression of the U.S. pharma industry

U.S. adults that believe physicians are under pressure from pharma to prescribe drugs

U.S. adults impression of the U.S. pharma drug qualities

U.S. adults impression of the U.S. pharma companies fairness towards patients

U.S. adults who would rate selected pharma features as excellent or good 2017

Preferred pharma companies by Americans for drug purchase 2017

Americans on US pharma quality compared to foreign pharma 2017